- Home
- Products
- Customized FluoroAb™
- PRLR
- Anti-PRLR MAb (Clone 2)-iFluor® 350 Succinimidyl Ester
Anti-PRLR MAb (Clone 2)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS863)
This product is comprised of an Chimeric Anti-PRLR IgG1-kappa (Clone 2) labeled with iFluor® 350 Succinimidyl Ester. iFluor® 350 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 345/450 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- PRLR
- Overview
- Chimeric Anti-PRLR IgG1-kappa (Clone 2)
- Species Reactivity
- Human
- Name
- iFluor® 350 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 345/450
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS863. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-050 | Anti-PRLR-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Taplitumomab paptox-iFluor 568 (CAT#: ADC-FL-367)
- Anti-CD4 MAb (Clone 22)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16535)
- Anti-MUC16 MAb (Clone 1)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14078)
- Anti-CD33 MAb (Clone 15)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13175)
- Anti-CD37 MAb (Clone 1)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS4783)
- Anti-CD44 MAb (Clone 3)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8206)
- Anti-APP MAb (Clone 10)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS13963)
- Anti-ACVR2B MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS148)
- Vepalimomab-iFluor 350 (CAT#: ADC-FL-073)
- Anti-TNFRSF8 MAb (Clone 3)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12664)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.